• Home  / 
  • Biotech News
  •  /  Novavax to Present at the Stifel 2017 Healthcare Conference

Novavax to Present at the Stifel 2017 Healthcare Conference

GAITHERSBURG, Md., Nov. 08, 2017 (GLOBE NEWSWIRE) — Novavax, Inc., (Nasdaq:NVAX) today announced the Company will present at the Stifel 2017 Healthcare Conference.
Presentation details are as follows:

Date: Wednesday, November 15, 2017
Time: 1:15 p.m. – 1:55 p.m. ET
Location: Garrison, 5th Floor, Lotte New York Palace Hotel, New York City

Live webcast: www.novavax.com, “Investors”/“Events”

A replay of the presentation will also be accessible under the “Investors/Events” section of the Novavax website at novavax.com.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company’s website, novavax.com.

Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Director, Investor & Media Relations
[email protected]
240-268-2000

Westwicke Partners
John Woolford
[email protected]
443-213-0506

Media
Russo Partners, LLC
David Schull
Maggie Beller
[email protected]
[email protected]
212-845-4271

  • The Safest Investment In Uncertain Times Is Gold. Get Started Here!
  • Survival Things Our Great-Grandfathers Did Around The House. Watch Video
  • Doctors Discover How To Reverse Diabetes. Learn More
Click here to add a comment

Leave a comment: